Atlas Trials

HER2-positive Solid Tumors

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HER2-positive Solid Tumors

RecordFirmDate
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929)Carisma Therapeutics Inc2021-02-02
Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors (NCT04521179)Jiangsu Alphamab Biopharmaceuticals Co., Ltd2020-12-07
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors (NCT04460456)Silverback Therapeutics2020-07-27
JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors (NCT04280341)Peking University2020-06-03
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors (NCT04278144)Bolt Biotherapeutics, Inc.2020-02-24
A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors (NCT04501770)Wuhan YZY Biopharma Co., Ltd.2018-09-27
A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients (NCT04189211)Bio-Thera Solutions2017-03-07

Track HER2-positive Solid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.